SCHEMBL1728187

SCHEMBL1728187

COc1ccccc1NC(=O)c1ccc(S(=O)(=O)C2CCc3ccccc3N2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ POLB P06746 1/20 0.48
▸ MLYCD O95822 1/20 0.46
▸ HPGD P15428 2/20 0.45
▸ MAPT P10636 4/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ LMNA P02545 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ APOBEC3A P31941 1/20 0.44
▸ EIF4H Q15056 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.44
▸ AHR P35869 1/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727761 0.87 KMT2A (0.41) ALDH1A1POLBSMN1; SMN2GAAMEN1
SCHEMBL1728014 0.87 NPC1 (0.45) POLBSMN1; SMN2TP53GAAMEN1
SCHEMBL1727825 0.84 RAB9A (0.52) ALDH1A1HPGDMAPTSMN1; SMN2TP53
SCHEMBL1726839 0.84 RAB9A (0.55) ALDH1A1SMN1; SMN2TP53MEN1KMT2A
SCHEMBL1727755 0.79 NAMPT (0.53) ALDH1A1POLBHPGDSMN1; SMN2MEN1
SCHEMBL1727750 0.78 KMT2A (0.47) ALDH1A1POLBMAPTTP53GAA
SCHEMBL1726674 0.78 NPC1 (0.52) POLBMAPTSMN1; SMN2TP53MEN1
SCHEMBL1727814 0.77 AKR1C3 (0.46) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL1727700 0.77 KMT2A (0.50) ALDH1A1POLBMAPTSMN1; SMN2TP53
SCHEMBL1728219 0.77 NAMPT (0.49) POLBMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403499-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL Stemsynergy Therapeutics, Inc (US) 2012-01-11 — — EP disclosed
WO-2010101964-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL STEMSYNERGY THERAPEUTICS, INC (US) 2010-09-10 — — WO disclosed
Send feedback